Podcast Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies
Tuesday, October 4, 2016
Podcast Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies
Related Posts:
Open Access Article:HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles
Most Accessed Article: CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies
Free Trial Offer
New Issue Published Current Cancer Drug Targets Vol 17 issue 7
Call For Paper
0 comments:
Post a Comment